mitomycin has been researched along with Dacryoadenitis in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"Past history of acute dacryocystitis was noted in 35." | 1.43 | Endoscopic ultrasonic dacryocystorhinostomy: clinical profile and outcomes. ( Ali, MJ; Chisty, N; Kamal, S; Naik, MN; Singh, M, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qian, Z | 1 |
Zhang, Y | 1 |
Fan, X | 1 |
Mukhtar, SA | 1 |
Jamil, AZ | 1 |
Ali, Z | 1 |
Ali, MJ | 1 |
Singh, M | 1 |
Chisty, N | 1 |
Kamal, S | 1 |
Naik, MN | 1 |
Rathore, PK | 1 |
Kumari Sodhi, P | 1 |
Pandey, RM | 1 |
1 review available for mitomycin and Dacryoadenitis
Article | Year |
---|---|
Clinical outcomes of dacryocystorhinostomy with or without intraoperative use of mitomycin C: a systematic review and meta-analysis.
Topics: Cicatrix; Dacryocystitis; Dacryocystorhinostomy; Drug Administration Schedule; Humans; Lacrimal Duct | 2014 |
3 other studies available for mitomycin and Dacryoadenitis
Article | Year |
---|---|
Efficacy of external dacryocystorhinostomy (DCR) with and without mitomycin-C in chronic dacryocystitis.
Topics: Adult; Dacryocystitis; Dacryocystorhinostomy; Female; Follow-Up Studies; Humans; Intraoperative Care | 2014 |
Endoscopic ultrasonic dacryocystorhinostomy: clinical profile and outcomes.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Dacryocystitis; Dacryocysto | 2016 |
Topical mitomycin C as a postoperative adjunct to endonasal dacryocystorhinostomy in patients with anatomical endonasal variants.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Dacryo | 2009 |